Chronic Myeloid Leukemia in a Patient With Multiple Sclerosis Treated With Interferon Beta-1a

Abstract

Hematological problems are commonly associated with the use of beta interferon (INF) such as leukopenia and anemia, which are usually benign and reversible when the drug is stop. We described a case of of a 29 years old patient with chronic myelogenous leukemia who had received INF beta-1a in the recent past for relapsing multiple sclerosis.